$1.14/ day, billed weekly
Cancel anytime

(Ads Free, Unlimited access)

NO CREDIT CARD REQUIRED

Gamida Cell Ltd (GMDAQ)GMDAQ

Gamida Cell Ltd

$0.02

Delayed price

PASS

BUY Advisory
Profitable SELL
Loss-Inducing SELL

Profit
Loss
PASS (Skip invest)*

Time period over

ALL
YEAR
MONTH
WEEK

Time period over

Upturn Advisory Summary

05/20/2024: GMDAQ (1-star) is currently NOT-A-BUY. Pass it for now.

Analysis of Past Performance

Type: Stock	Upturn Star Rating	Today’s Advisory: PASS
Historic Profit: -28.66%	Upturn Advisory Performance 3	Avg. Invested days: 29
Profits based on simulation	Stock Returns Performance 1	Last Close 05/20/2024

Type: Stock	Today’s Advisory: PASS
Historic Profit: -28.66%	Avg. Invested days: 29
Upturn Star Rating	Stock Returns Performance 1
Profits based on simulation Last Close 05/20/2024	Upturn Advisory Performance 3

Key Highlights

Company Size ETF	Market Capitalization 0 USD
Price to earnings Ratio -	1Y Target Price -
Dividends yield (FY) -	Basic EPS (TTM) -
Volume (30-day avg) 1423512	Beta -
52 Weeks Range 0.01 - 2.51	Updated Date 04/16/2024

Company Size ETF	Market Capitalization 0 USD	Price to earnings Ratio -	1Y Target Price -
Dividends yield (FY) -	Basic EPS (TTM) -	Volume (30-day avg) 1423512	Beta -
52 Weeks Range 0.01 - 2.51	Updated Date 04/16/2024

Earnings Date

Report Date -	When -
Estimate -	Actual -

Report Date -

When -

Estimate -

Actual -

Profitability

Profit Margin -

Operating Margin (TTM) -

Management Effectiveness

Return on Assets (TTM) -

Return on Equity (TTM) -

Valuation

Trailing PE -	Forward PE -
Enterprise Value -	Price to Sales(TTM) -
Enterprise Value to Revenue -	Enterprise Value to EBITDA -
Shares Outstanding -	Shares Floating -
Percent Insiders -	Percent Institutions -

Trailing PE -	Forward PE -	Enterprise Value -	Price to Sales(TTM) -
Enterprise Value to Revenue -	Enterprise Value to EBITDA -	Shares Outstanding -	Shares Floating -
Percent Insiders -	Percent Institutions -

Analyst Ratings

Rating 3.5	Target Price -	Buy 1
Strong Buy -	Hold 1	Sell -
Strong Sell -

Rating 3.5	Target Price -	Buy 1	Strong Buy -
Hold 1	Sell -	Strong Sell -

About Gamida Cell Ltd

Exchange	NASDAQ	Headquaters	Boston, MA, United States
IPO Launch date	-	President, CEO & Director	Ms. Abigail L. Jenkins M.S.
Sector	Healthcare	Website	https://www.gamida-cell.com
Industry	Biotechnology	Full time employees	145
Headquaters	Boston, MA, United States
President, CEO & Director	Ms. Abigail L. Jenkins M.S.
Website	https://www.gamida-cell.com
Website	https://www.gamida-cell.com
Full time employees	145

Gamida Cell Ltd. researches, develops, and commercializes cell therapies. The company offers Omisirge (omidubicel-onlv), a cell therapy for use in treatment of patients with hematologic malignancies and severe aplastic anemia. Its product candidate includes GDA-201, an investigational NK cell-based cancer immunotherapy, for the treatment of hematologic and solid tumors, as well as to treat follicular and diffuse large B-cell lymphomas which is in phase 1 of phase1/2 clinical trial. The company was incorporated in 1998 and is based in Boston, Massachusetts.

https://www.upturn.io

Disclosure Privacy Policy Terms of Use Sitemap Contact Us

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.